clavulanic acid has been researched along with erythromycin in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (16.67) | 18.7374 |
1990's | 10 (33.33) | 18.2507 |
2000's | 9 (30.00) | 29.6817 |
2010's | 5 (16.67) | 24.3611 |
2020's | 1 (3.33) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cioce, C; Facchini, M; Pestalozza, G | 1 |
Bingen, E; Bourgeois, F; Chardon, H; Doit, C; Lambert-Zechovsky, N | 1 |
Abu-Fanas, SH; Drucker, DB; Ganguli, LA; Hull, PS; Reeder, JC | 1 |
Ducroix, JP; Gaudio, F; Laurans, G; Orfila, J | 1 |
Haboubi, NY; Lee, GS; Montgomery, RD | 1 |
Bergeron, MG; L'Ecuyer, J; Provencher, P; Tremblay, LD | 1 |
Escoubas, J; Fouche, J; Mormede, M; Texier-Maugein, J | 1 |
Sturm, AW | 1 |
Chapin, KC; Doern, GV | 1 |
Gezelius, L; Liljequist, BO | 1 |
Schmid, GP | 1 |
Geubel, AP; Horsmans, Y | 1 |
Aleo, G; Blandino, G; Caccamo, F; Nicolosi, VM; Siracusa, V; Speciale, A | 1 |
Jradeh, M; Shihab, Z; Uwaydah, M | 1 |
Eliopoulos, GM; Souli, M; Wennersten, CB | 1 |
Gaillat, J | 1 |
Aguilar, L; Carcas, A; Cenjor, C; Garcia-Olmos, M; Gimenez, MJ; Parra, A; Ponte, C; Soriano, F | 1 |
Lee, WK; Young, BW | 1 |
Egawa, S; Endo, K; Hosobe, T; Kiyota, H; Kobayashi, I; Onodera, S; Suzuki, H; Takahashi, T | 1 |
Chung, JH; Clock, CA; Ehsanipoor, RM; McNulty, JA; Wing, DA | 1 |
Lilenbaum, W; Martins, GM; Martins, RR; Medeiros, L; Penna, B; Varges, R | 1 |
Herath, SC; Maisey, S; Normansell, R; Poole, P | 1 |
Chaleshtori, RS; Emami, MS; Rahimi, E; Shakerian, A | 1 |
3 review(s) available for clavulanic acid and erythromycin
Article | Year |
---|---|
The treatment of chancroid.
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Chancroid; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Erythromycin; Haemophilus ducreyi; Humans; Penicillin Resistance; Rifampin; Sulfonamides; Trimethoprim | 1986 |
[Objectives for antibiotic therapy in acute exacerbations of chronic bronchitis].
Topics: Acute Disease; Adrenal Cortex Hormones; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bronchitis, Chronic; Ciprofloxacin; Clavulanic Acid; Clinical Trials as Topic; Cost-Benefit Analysis; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Humans; Maximal Expiratory Flow-Volume Curves; Multicenter Studies as Topic; Penicillins; Placebos; Practice Guidelines as Topic; Prognosis; Recurrence; Respiratory Function Tests; Tetracycline; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2001 |
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Disease Progression; Drug Administration Schedule; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic; Roxithromycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
2 trial(s) available for clavulanic acid and erythromycin
Article | Year |
---|---|
Azithromycin in upper respiratory tract infections: a clinical trial in children with otitis media.
Topics: Administration, Oral; Amoxicillin; Azithromycin; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Follow-Up Studies; Humans; Infant; Male; Otitis Media; Otitis Media with Effusion | 1992 |
The treatment of chancroid.
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Chancroid; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Erythromycin; Haemophilus ducreyi; Humans; Penicillin Resistance; Rifampin; Sulfonamides; Trimethoprim | 1986 |
26 other study(ies) available for clavulanic acid and erythromycin
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Child; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis | 1992 |
Identification, and susceptibility to seven antimicrobial agents, of 61 gram-negative anaerobic rods from periodontal pockets.
Topics: Amoxicillin; Anaerobiosis; Anti-Bacterial Agents; Bacteriological Techniques; Bacteroides; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Erythromycin; Fusobacterium; Humans; Metronidazole; Minocycline; Penicillin Resistance; Penicillin V; Periodontal Pocket; Periodontitis; Tetracycline Resistance | 1991 |
[In vitro activity of cefuroxime against Moraxella (Branhamella) catarrhalis].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cefuroxime; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythromycin; In Vitro Techniques; Moraxella catarrhalis | 1991 |
Duodenal mucosal morphometry of elderly patients with small intestinal bacterial overgrowth: response to antibiotic treatment.
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Biopsy; Clavulanic Acid; Clavulanic Acids; Duodenitis; Enterobacteriaceae; Enterobacteriaceae Infections; Erythromycin; Female; Humans; Image Processing, Computer-Assisted; Intestinal Mucosa; Male; Microscopy; Tetracycline | 1991 |
Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Canada; Cefaclor; Cefamandole; Cefazolin; Cefotaxime; Cefuroxime; Chloramphenicol; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Enzyme Inhibitors; Erythromycin; Haemophilus influenzae; Rifampin; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
[Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; beta-Lactamases; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Doxycycline; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Respiratory Tract Infections | 1988 |
Haemophilus influenzae and Haemophilus parainfluenzae in nongonococcal urethritis.
Topics: Amoxicillin; Clavulanic Acid; Clavulanic Acids; Erythromycin; Haemophilus; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Urethritis | 1986 |
Susceptibility of Haemophilus influenzae to amoxicillin/clavulanic acid, erythromycin, cefaclor, and trimethoprim/sulfamethoxazole.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Erythromycin; Haemophilus influenzae; Humans; Infant; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
Topics: Amoxicillin; Ampicillin; beta-Lactamases; Cefaclor; Cefuroxime; Cephaloridine; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests; Neisseriaceae; Penicillin G | 1986 |
Amoxycillin-clavulanic acid-erythromycin cross-liver toxicity: a case report.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Clavulanic Acid; Clavulanic Acids; Erythromycin; Humans; Liver; Male | 1994 |
In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefdinir; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Moraxella catarrhalis; Penicillins; Sicily; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 1996 |
Antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Lebanon.
Topics: Amoxicillin; Cefaclor; Ceftriaxone; Chloramphenicol; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Humans; Lebanon; Penicillin G; Streptococcus pneumoniae; Tetracycline | 1996 |
In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens.
Topics: Amoxicillin; Anti-Infective Agents; Aza Compounds; Cefuroxime; Clavulanic Acid; Erythromycin; Fluoroquinolones; Methicillin Resistance; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Penicillin Resistance; Quinolines; Quinolones; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae; Streptococcus pyogenes | 1998 |
Does acetaminophen interfere in the antibiotic treatment of acute otitis media caused by a penicillin-resistant pneumococcus strain? A gerbil model.
Topics: Acetaminophen; Acute Disease; Amoxicillin; Analgesics, Non-Narcotic; Animals; Anti-Bacterial Agents; Clavulanic Acid; Disease Models, Animal; Drug Interactions; Erythromycin; Female; Gerbillinae; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 2003 |
Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Clavulanic Acid; Community-Acquired Infections; Drug Prescriptions; Erythromycin; Hong Kong; Humans; Infant; Penicillin Resistance; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Prevalence; Streptococcus pneumoniae | 2005 |
Enhancement of antimicrobial activities of cefteram or clavulanic acid/amoxicillin against cefixime-resistant Neisseria gonorrhoeae in the presence of clarithromycin or azithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Cefixime; Cefmenoxime; Clarithromycin; Clavulanic Acid; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Humans; Male; Neisseria gonorrhoeae | 2006 |
A retrospective review of ampicillin-sulbactam and amoxicillin + clavulanate vs cefazolin/cephalexin and erythromycin in the setting of preterm premature rupture of membranes: maternal and neonatal outcomes.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Cephalexin; Chorioamnionitis; Clavulanic Acid; Drug Therapy, Combination; Endometritis; Enterocolitis, Necrotizing; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Pregnancy; Pregnancy Outcome; Retrospective Studies; Sulbactam | 2008 |
Species distribution and antimicrobial susceptibility of staphylococci isolated from canine otitis externa.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Clavulanic Acid; Dog Diseases; Dogs; Drug Resistance, Bacterial; Drug Therapy, Combination; Erythromycin; Female; Male; Microbial Sensitivity Tests; Neomycin; Otitis Externa; Oxacillin; Staphylococcal Skin Infections; Staphylococcus | 2010 |
Distribution of Virulence Genes in
Topics: Agaricus; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Clavulanic Acid; Erythromycin; Gentamicins; Humans; Iran; Nalidixic Acid; Virulence | 2023 |